Financial experts highlight automated investing as a key habit to adopt in 2026 for building a $1 million retirement portfolio. By setting recurring investments into diversified assets, investors can ...
Pfizer shows steady pharmaceutical progress with oncology growth and drug protection strength, shaping healthcare dynamics ...
The U.S. Food and Drug Administration on Friday approved Pfizer ​and Arvinas' breast cancer drug for patients with an ...
24/7 Wall St. on MSN
Just five dividend stocks transform $500,000 into $3,100 a month in retirement income
Quick Read A $500,000 portfolio split equally across Realty Income (O), Ares Capital (ARCC), Enterprise Products Partners ...
Pfizer (PFE) stock and Arvinas (ARVN) stock are in focus as the FDA approves the companies' breast cancer drug, Veppanu. Read ...
VEPPANU™ is the first-and-only FDA-approved PROTAC, a type of heterobifunctional protein degrader –– Approval received in advance of ...
Pfizer Inc. (NYSE:PFE) is one of the 10 Best Medical Stocks to Buy Under $30. On April 20, Pfizer Inc. (NYSE:PFE) announced, ...
Pfizer said on Wednesday its drug Elrexfio met the main goal in a ​late-stage trial that tested the blood cancer ‌treatment ...
Pfizer Inc. (NYSE:PFE) is one of the most active US stocks to buy right now. On April 28, Pfizer entered into settlement ...
Vyndamax, which treats heart problems in adults with cardiomyopathy, along with its related drugs, generated $6.3 billion in ...
Pfizer PFE is set to report its first-quarter 2026 earnings on May 5, before market open. The Zacks Consensus Estimate for ...
Get a deeper insight into the potential performance of Pfizer (PFE) for the quarter ended March 2026 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results